British regulators said on Friday that the reprimand followed a voluntary submission by Novo about the payments
has been reprimanded by U.K. regulators for failing to disclose fees and expenses paid to individuals and organizations in Britain amounting to about £7.8-million between 2020 and 2022.
Novo, whose valuation has soared following the success of its diabetes drug Ozempic and weight loss treatment Wegovy, said on Friday that it had made the voluntary admission in 2023 after it found historical payments that had not been disclosed. “We accept the PMCPA’s decision to rule the relevant breaches of the two Codes of Practice which applied during the time frame for this case and agreed that this was the appropriate ruling as part of our voluntary admission.”
Practice Pmcpa Code Body Group Abpi Admission Novo Novartis Pfizer
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk, Eli Lilly still top 2 pharma stocks: AnalystNovo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as...
Read more »
Novo Nordisk stock rises on Wegovy approval in ChinaShares of Novo Nordisk (NVO) are soaring to an all-time high after its popular GLP-1 weight-loss drug, Wegovy, was approved in China. Yahoo Finance's Anjalee...
Read more »
Ozempic Maker Novo Nordisk Plans Another $4.1 Billion US FactoryNovo Nordisk A/S plans to invest $4.1 billion in another US factory, plowing more money into its biggest market amid rising discontent there over the cost of its obesity and diabetes drugs.
Read more »
Novo Nordisk says no sign of crime, links between fires at Danish facilities over past monthA fire at a building near the company’s Bagsvaerd head office northwest of Copenhagen on Tuesday was the third in just over one month at different facilities occupied by Novo Nordisk
Read more »
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a monthCOPENHAGEN, Denmark (AP) — A fire broke out Tuesday at an office building belonging to Danish pharmaceutical company Novo Nordisk, the third in a little more...
Read more »
Third fire in about a month breaks out at building of Wegovy drugmaker Novo NordiskA fire broke out Tuesday at an office building belonging to Danish pharmaceutical company Novo Nordisk, the third in a little more over a month to hit the drugmaker.
Read more »